Home » Topics » Regulatory » Patents

Patents
RSS

Genentech and University of California, Oakland disclose IRE1 inhibitors

Oct. 8, 2018

U.S. researchers divulge bacterial efflux pump inhibitors

Oct. 8, 2018

UMC Utrecht Holding synthesizes modified serpins for bradykinin-mediated diseases

Oct. 8, 2018

U.S. researchers divulge MALT1 inhibitors

Oct. 5, 2018

Janssen identifies new BACE inhibitors

Oct. 5, 2018

Takeda Pharmaceutical divulges new orexin OX2 receptor agonists

Oct. 5, 2018

Nimbus Lakshmi patents TYK2 inhibitors

Oct. 5, 2018

Theravance Biopharma divulges JAK inhibitors

Oct. 4, 2018

French researchers patent new beta-lactamase inhibitors

Oct. 4, 2018

Yogee's Bioinnovations discloses cathepsin D and angiogenesis inhibitors

Oct. 4, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...